Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018
December 10, 2018 08:08 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying...
Abattis Announces Acquisition of Fertilizer Company NutriVida
December 07, 2018 18:13 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding...
Abattis Comments on BCSC Temporary Order
November 27, 2018 18:45 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British...
Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Naturals
November 26, 2018 16:29 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first...
Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank
November 23, 2018 13:05 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a...
Abattis Retains Canadian and American Compliance Agency and Provides Company Update
November 21, 2018 08:00 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient...
Abattis Bioceuticals Celebrates Legalization
October 17, 2018 19:52 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in...
Abattis Bioceuticals Provides Update on Vaporizer Product Line
October 11, 2018 17:16 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce an update on our recent product...
Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
October 04, 2018 12:53 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTC: ATTBF) is pleased to announce that the research being done in...
Abattis Unveils “Comfort”, Its Proprietary New Chronic Pain and Inflammation Product to Start Shipping November 2018
September 24, 2018 09:44 ET
|
Abattis Bioceuticals Corp.
VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the pending release of “Comfort”,...